{
    "applicationNumber": "BR 11 2022 022366-8",
    "filingDate": "30/04/2021",
    "grantDate": null,
    "title": "DERIVADOS DE 4-(2,6-DIFLUOROFEN\u00d3XI)-6-(TRIFLUOROMETIL)PIRIMIDIN-2-AMINA COMO PONTENCIALIZADORES DO RECEPTOR HMRGX1 PARA O TRATAMENTO DA DOR",
    "nationalPhaseDate": [
        "03/11/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2021/030100",
        "pctDate": "30/04/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "63/021,806",
            "priorityDate": "08/05/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2706"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2710"
        }
    ],
    "inventors": [
        "DARYL LYNN SMITH",
        "LEONARD LARRY WINNEROSKI JR"
    ],
    "holders": [
        87687
    ],
    "ipcCodes": [
        "A61P 25/04",
        "C07D 239/46",
        "A61K 31/505"
    ]
}